LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical company engaged in the development and commercialization of human therapeutics, today announced that it is set to join the reconstituted Russell 3000® Index. Final membership in the Russell 3000 Index will be announced June 22, 2007. A preliminary list of Russell 3000 Index additions is available on the Russell Investment Group Web site at www.russell.com.
